Does treatment with the arginase inhibitor Nw-hydroxy-nor-L-arginine restore endothelial function in rat adjuvant-induced arthritis?
The treatment with an arginase inhibitor has a potent effect on ED in AIA independently of the severity of the disease. Our results suggest that this new pharmacological approach has the potential as a novel add-on therapy in the treatment of RA.
These results suggest that whole blood EBV-DNA quantitation might be of value as a convenient biomarker for therapeutic responsiveness of NHL.